A structured commons for cancer education, understanding, and research

This application is designed to educate and provide a reliable, navigable resource for the study and understanding of cancer.

It is not intended to provide medical advice or treatment recommendations.

While access is subscription-based, the app is independently developed, scientifically grounded, and free from corporate incentives or advertising pressures.

By providing structured access to cancer biology, treatment paradigms, and research context, the app aims to empower users—from the public to scientific professionals—with knowledge that supports better understanding, inquiry, and informed discussion.

The developer is a multi-degreed scientific researcher, but not a medical doctor.

This application is an educational and informational resource. It is not intended to provide medical advice, clinical guidance, or treatment recommendations.

The developer’s credentials include genetic engineering, cancer biology, and related disciplines. The developer is not an oncologist and does not hold formal medical training. All content should be interpreted within this context and used for learning and research purposes only.

What's Inside

A Multi-Perspective System

  • Six lensesLayperson, Patient, Pre-Clinician, PCP, Oncologist, Researcher—present the same knowledge at the right depth and language for each audience.
  • Cancer Sub-FieldsProgressive content releases cover a wide range of cancer types and subtypes, starting with foundational areas before expanding further.
  • Multi-Faceted ApproachExplore biology, genetics, treatment, patient experience, clinical challenges, pharmacology, and research frontiers—all integrated in one system.
  • Adaptive ReviewSpaced repetition and mastery tracking help reinforce learning and identify gaps across all perspectives.
  • Context That MattersScientific information is distilled clearly without losing nuance, preserving accuracy and evidence.
  • Private by DesignFully offline capable, no ads or tracking. Your study remains yours, with subscription support for ongoing development.